|
1,1,1-Trifluoro-N-(2-hydroxyethyl)methanesulfonamide
|
T770366-5g
|
≥95% |
40630-40-8 |
5g
|
¥ 306.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,1,1-Trifluoro-N-(2-hydroxyethyl)methanesulfonamide
|
T770366-25g
|
≥95% |
40630-40-8 |
25g
|
¥ 1042.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,1,1-Trifluoro-N-(2-hydroxyethyl)methanesulfonamide
|
T770366-100g
|
≥95% |
40630-40-8 |
100g
|
¥ 3328.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,1,1-三氟-n,n-二甲基甲磺酰胺
|
T770360-5g
|
≥98% |
28048-17-1 |
5g
|
¥ 478.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,1,1-三氟-n,n-二甲基甲磺酰胺
|
T770360-1g
|
≥98% |
28048-17-1 |
1g
|
¥ 146.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,1,1-三氟-n,n-二甲基甲磺酰胺
|
T770360-10g
|
≥98% |
28048-17-1 |
10g
|
¥ 923.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-(苯并[b]噻吩-4-基)哌嗪-1-羧酸叔丁酯
|
T770359-5g
|
≥95% |
1191901-07-1 |
5g
|
¥ 674.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-(苯并[b]噻吩-4-基)哌嗪-1-羧酸叔丁酯
|
T770359-1g
|
≥95% |
1191901-07-1 |
1g
|
¥ 192.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(乙酰硫基)氮杂环丁烷-1-羧酸叔丁酯
|
T770349-250mg
|
≥95% |
183800-74-0 |
250mg
|
¥ 2130.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
噻吩并[3,2-b]噻吩-2,5-二羧酸
|
T770328-250mg
|
≥95% |
18646-81-6 |
250mg
|
¥ 2913.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
噻吩并[3,2-b]噻吩-2,5-二羧酸
|
T770328-100mg
|
≥95% |
18646-81-6 |
100mg
|
¥ 1714.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,4,5,8-四羟基-2,3-二氢蒽-9,10-二酮
|
T770316-5g
|
≥97% |
81-59-4 |
5g
|
¥ 568.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,4,5,8-四羟基-2,3-二氢蒽-9,10-二酮
|
T770316-25g
|
≥97% |
81-59-4 |
25g
|
¥ 1985.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,4,5,8-四羟基-2,3-二氢蒽-9,10-二酮
|
T770316-1g
|
≥97% |
81-59-4 |
1g
|
¥ 162.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,2',2‘'-[1,3,5-三嗪-2,4,6-三乙氧基]三乙醇
|
T770267-250mg
|
≥97% |
891-65-6 |
250mg
|
¥ 331.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,2',2‘'-[1,3,5-三嗪-2,4,6-三乙氧基]三乙醇
|
T770267-1g
|
≥97% |
891-65-6 |
1g
|
¥ 871.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
四丙基硫酸氢铵
|
T770262-5g
|
≥98% |
56211-70-2 |
5g
|
¥ 166.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
四丙基硫酸氢铵
|
T770262-25g
|
≥98% |
56211-70-2 |
25g
|
¥ 713.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
四丙基硫酸氢铵
|
T770262-1g
|
≥98% |
56211-70-2 |
1g
|
¥ 40.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,3S,5S)-5-叔丁氧基甲酰氨基-2-氨基-3-羟基-1,6-二苯基己烷琥珀酸盐 (抗爱滋病药利托那韦中间体BDH琥珀酸盐)
|
T770230-50g
|
≥98% |
183388-64-9 |
50g
|
¥ 1185.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,3S,5S)-5-叔丁氧基甲酰氨基-2-氨基-3-羟基-1,6-二苯基己烷琥珀酸盐 (抗爱滋病药利托那韦中间体BDH琥珀酸盐)
|
T770230-2g
|
≥98% |
183388-64-9 |
2g
|
¥ 120.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,3S,5S)-5-叔丁氧基甲酰氨基-2-氨基-3-羟基-1,6-二苯基己烷琥珀酸盐 (抗爱滋病药利托那韦中间体BDH琥珀酸盐)
|
T770230-10g
|
≥98% |
183388-64-9 |
10g
|
¥ 474.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
三丁胺(二氯亚甲基)二(膦酸酯)
|
T770223-5g
|
≥95% |
163706-61-4 |
5g
|
¥ 897.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
三丁胺(二氯亚甲基)二(膦酸酯)
|
T770223-25g
|
≥95% |
163706-61-4 |
25g
|
¥ 3892.9
|
期货,请咨询 |
|
0 |
阿拉丁 |